Media Summary: Matthew Durdy, Chief Executive, Cell and Gene AT-TV Overcoming manufacturing challenges for advanced therapies WuXi App Tec is a rapidly-growing global enterprise providing an integrated service for

Tackling Manufacturing Challenges In Advanced Therapies - Detailed Analysis & Overview

Matthew Durdy, Chief Executive, Cell and Gene AT-TV Overcoming manufacturing challenges for advanced therapies WuXi App Tec is a rapidly-growing global enterprise providing an integrated service for "We are at the forefront of science and medicine right now", Samantha Dykes highlights in the first episode of "Cell Insider" by BBG ... Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, describes An excerpt from Cell & Gene Live's How To Reduce Batch-to-Batch Variation In Cell

In this part of our discussion during the Cell & Gene Live, Unlocking the Potential of iPSC In this engaging video, our experts are delving into the innovative strategies and transformative potential of employing a platform ... Monica Shah, MD, IQVIA, Washington, D.C., discusses ongoing hurdles that need to be overcome in Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., discusses the ... This presentation focuses on AI, digitization, and their impact on healthcare, with a strong emphasis on patient-centered ... This webinar is part of a four-part series providing an overview of gene therapies and

Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ... Biomatics' Director Andreea Iftimia-Mander joined the Oh Industry 4.0 panel at

Photo Gallery

Tackling manufacturing challenges in advanced therapies
AT-TV | Overcoming manufacturing challenges for advanced therapies
Challenges in Manufacturing of Advanced Therapies and Immunotherapeutics - Alan Moore - RB2016
Advanced therapy manufacturing needs a boost, and AutoloMATE can help
Transforming the Wild Frontier – Industrialization of Advanced Therapies Workshop
BBG Advanced Therapies Cell Insider - episode 1
Challenges in manufacturing viral vectors for the clinic
GCT Manufacturing | Vector Production | Autologous and Allogeneic | Stem Cells |Supply Chain
The Biggest Challenges in Autologous Cell Therapy Manufacturing
The Biggest Challenges in Allogeneic Cell Therapy Manufacturing
Overcoming Manufacturing Hurdles to Scale iPSC Therapies
Advanced Therapies Accelerator Launch film
Sponsored
Sponsored
View Detailed Profile
Tackling manufacturing challenges in advanced therapies

Tackling manufacturing challenges in advanced therapies

Matthew Durdy, Chief Executive, Cell and Gene

AT-TV | Overcoming manufacturing challenges for advanced therapies

AT-TV | Overcoming manufacturing challenges for advanced therapies

AT-TV | Overcoming manufacturing challenges for advanced therapies

Sponsored
Challenges in Manufacturing of Advanced Therapies and Immunotherapeutics - Alan Moore - RB2016

Challenges in Manufacturing of Advanced Therapies and Immunotherapeutics - Alan Moore - RB2016

WuXi App Tec is a rapidly-growing global enterprise providing an integrated service for

Advanced therapy manufacturing needs a boost, and AutoloMATE can help

Advanced therapy manufacturing needs a boost, and AutoloMATE can help

The

Transforming the Wild Frontier – Industrialization of Advanced Therapies Workshop

Transforming the Wild Frontier – Industrialization of Advanced Therapies Workshop

As the cell and gene

Sponsored
BBG Advanced Therapies Cell Insider - episode 1

BBG Advanced Therapies Cell Insider - episode 1

"We are at the forefront of science and medicine right now", Samantha Dykes highlights in the first episode of "Cell Insider" by BBG ...

Challenges in manufacturing viral vectors for the clinic

Challenges in manufacturing viral vectors for the clinic

Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, describes

GCT Manufacturing | Vector Production | Autologous and Allogeneic | Stem Cells |Supply Chain

GCT Manufacturing | Vector Production | Autologous and Allogeneic | Stem Cells |Supply Chain

The modes of GCT

The Biggest Challenges in Autologous Cell Therapy Manufacturing

The Biggest Challenges in Autologous Cell Therapy Manufacturing

An excerpt from Cell & Gene Live's How To Reduce Batch-to-Batch Variation In Cell

The Biggest Challenges in Allogeneic Cell Therapy Manufacturing

The Biggest Challenges in Allogeneic Cell Therapy Manufacturing

An excerpt from Cell & Gene Live's How To Reduce Batch-to-Batch Variation In Cell

Overcoming Manufacturing Hurdles to Scale iPSC Therapies

Overcoming Manufacturing Hurdles to Scale iPSC Therapies

In this part of our discussion during the Cell & Gene Live, Unlocking the Potential of iPSC

Advanced Therapies Accelerator Launch film

Advanced Therapies Accelerator Launch film

Advanced therapies

Accelerate Time to Clinic for Advanced Therapies with a Platform Approach

Accelerate Time to Clinic for Advanced Therapies with a Platform Approach

In this engaging video, our experts are delving into the innovative strategies and transformative potential of employing a platform ...

Addressing key issues in manufacturing advanced therapies

Addressing key issues in manufacturing advanced therapies

Monica Shah, MD, IQVIA, Washington, D.C., discusses ongoing hurdles that need to be overcome in

The challenges of CMC in cell and gene therapies

The challenges of CMC in cell and gene therapies

Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., discusses the ...

Overcoming ATMP Challenges: Gene Therapies, Regulatory Hurdles, and Scalable Manufacturing

Overcoming ATMP Challenges: Gene Therapies, Regulatory Hurdles, and Scalable Manufacturing

This presentation focuses on AI, digitization, and their impact on healthcare, with a strong emphasis on patient-centered ...

Webinar: What are advanced therapies?

Webinar: What are advanced therapies?

This webinar is part of a four-part series providing an overview of gene therapies and

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ...

Biomatics at Advanced Therapies Integrates

Biomatics at Advanced Therapies Integrates

Biomatics' Director Andreea Iftimia-Mander joined the Oh Industry 4.0 panel at

Key Considerations for Advanced Therapies Manufacturing

Key Considerations for Advanced Therapies Manufacturing

"Key Considerations for